Background Percutaneous coronary intervention (PCI) with drug-eluting stents is the
standard of care for treatment of native coronary artery stenoses, but optimum treatment …

Objectives: This study sought to assess the long-term clinical outcome of patients with
spontaneous coronary artery dissection (SCD) managed with a conservative strategy …

Objectives: This study sought to investigate the clinical impact of the use of intravascular
ultrasound (IVUS) during revascularization of patients with left main coronary artery (LM) …

Aims Consensus is lacking regarding the best treatment for coronary in-stent restenosis
(ISR). The two most effective treatments are angioplasty with paclitaxel-coated balloon …

Background In patients with coronary in-stent restenosis (ISR) requiring reintervention, it is
unclear if the choice of treatment should depend on whether the restenotic stent was a bare …

Objectives: This study sought to assess the effectiveness of a strategy of using drug-eluting
stents (DES) with a different drug (switch) in patients with DES in-stent restenosis (ISR) …

Objectives: A meta-analysis of 11 randomized trials was done to compare stenting versus
balloon angioplasty (BA) in small coronary vessels. Background: Randomized studies on …

Objective This prospective study sought to assess the diagnostic value of optical coherence
tomography (OCT) compared with intravascular ultrasound (IVUS) in patients presenting …

Abstract Treatment of patients with in-stent restenosis (ISR) remains a technical challenge.
This problem has been reduced since the advent of drug-eluting stents (DES), but continues …

To the Editor: Drug-eluting stents (DES) represent a breakthrough in interventional
cardiology but have been unable to reduce the incidence of stent thrombosis (1–2). Delayed …